This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The University of Melbourne, Tianli Biotech Pty Ltd. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Trudi Harris: Innovator in Respiratory Disease Treatment
Introduction
Trudi Harris is a notable inventor based in Victoria, Australia. She has made significant contributions to the field of respiratory disease treatment, holding a total of 3 patents. Her work focuses on innovative methods and compositions aimed at improving the lives of individuals suffering from respiratory conditions.
Latest Patents
Trudi Harris's latest patents revolve around the treatment of respiratory diseases. One of her key inventions involves compositions, methods, and kits designed for the treatment or prevention of exacerbations of asthma and chronic obstructive pulmonary disease. The methods she developed include administering a therapeutically effective amount of an inhibitor of casein kinase 1 or an inhibitor of ALK5 directly to the airway and/or lungs. These inventions aim to treat or prevent respiratory diseases and conditions involving fibrosis in subjects in need.
Career Highlights
Throughout her career, Trudi has worked with esteemed organizations such as the University of Melbourne and Tianli Biotech Pty Ltd. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Trudi has had the opportunity to work alongside talented individuals, including Christine Keenan and Alastair George Stewart. These collaborations have enriched her research and innovation efforts.
Conclusion
Trudi Harris stands out as an influential inventor in the realm of respiratory disease treatment. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
